DE1239291B - Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compounds - Google Patents
Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compoundsInfo
- Publication number
- DE1239291B DE1239291B DE1964F0042610 DEF0042610A DE1239291B DE 1239291 B DE1239291 B DE 1239291B DE 1964F0042610 DE1964F0042610 DE 1964F0042610 DE F0042610 A DEF0042610 A DE F0042610A DE 1239291 B DE1239291 B DE 1239291B
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- radical
- branched
- alicyclic
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 aromatic polycyclic carbonyl compounds Chemical class 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 5
- MXWHMTNPTTVWDM-NXOFHUPFSA-N mitoguazone Chemical compound NC(N)=N\N=C(/C)\C=N\N=C(N)N MXWHMTNPTTVWDM-NXOFHUPFSA-N 0.000 title description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 150000007857 hydrazones Chemical class 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 5
- 125000002723 alicyclic group Chemical group 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 5
- 230000003000 nontoxic effect Effects 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical class NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229930194542 Keto Natural products 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 150000001491 aromatic compounds Chemical class 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000007859 condensation product Substances 0.000 claims description 2
- 150000001912 cyanamides Chemical class 0.000 claims description 2
- 150000002429 hydrazines Chemical class 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 150000003583 thiosemicarbazides Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000000354 decomposition reaction Methods 0.000 description 8
- 241000700199 Cavia porcellus Species 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 210000004165 myocardium Anatomy 0.000 description 6
- 210000002837 heart atrium Anatomy 0.000 description 5
- 230000009090 positive inotropic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 241000700198 Cavia Species 0.000 description 4
- 206010062575 Muscle contracture Diseases 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 208000006111 contracture Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XWZKPVAYNUXKCZ-UHFFFAOYSA-N 1-(5-acetylnaphthalen-1-yl)ethanone Chemical compound C1=CC=C2C(C(=O)C)=CC=CC2=C1C(C)=O XWZKPVAYNUXKCZ-UHFFFAOYSA-N 0.000 description 3
- 108091006112 ATPases Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RZGGOKRYQZPJQD-UHFFFAOYSA-N (6-benzoylpyren-1-yl)-phenylmethanone Chemical compound C=1C=C(C2=C34)C=CC3=C(C(=O)C=3C=CC=CC=3)C=CC4=CC=C2C=1C(=O)C1=CC=CC=C1 RZGGOKRYQZPJQD-UHFFFAOYSA-N 0.000 description 2
- XRHLZWNTCOKXCJ-UHFFFAOYSA-N 1-(5-acetyl-2,6-dihydroxynaphthalen-1-yl)ethanone Chemical compound OC1=CC=C2C(C(=O)C)=C(O)C=CC2=C1C(C)=O XRHLZWNTCOKXCJ-UHFFFAOYSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- MGRRGKWPEVFJSH-UHFFFAOYSA-N 10-(10-oxoanthracen-9-ylidene)anthracen-9-one Chemical compound C12=CC=CC=C2C(=O)C2=CC=CC=C2C1=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MGRRGKWPEVFJSH-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- VOICENUZWLJCFE-UHFFFAOYSA-N (10-benzoylanthracen-9-yl)-phenylmethanone Chemical compound C=12C=CC=CC2=C(C(=O)C=2C=CC=CC=2)C2=CC=CC=C2C=1C(=O)C1=CC=CC=C1 VOICENUZWLJCFE-UHFFFAOYSA-N 0.000 description 1
- DKSJRIWNWIRVCV-UHFFFAOYSA-N (4-benzoylnaphthalen-1-yl)-phenylmethanone Chemical compound C=1C=C(C(=O)C=2C=CC=CC=2)C2=CC=CC=C2C=1C(=O)C1=CC=CC=C1 DKSJRIWNWIRVCV-UHFFFAOYSA-N 0.000 description 1
- OUACHDIGJXGWRQ-UHFFFAOYSA-N (5-benzoyl-2,6-dimethylnaphthalen-1-yl)-phenylmethanone Chemical compound C(C1=CC=CC=C1)(=O)C1=C(C=CC2=C(C(=CC=C12)C)C(C1=CC=CC=C1)=O)C OUACHDIGJXGWRQ-UHFFFAOYSA-N 0.000 description 1
- UJBRSMKKNNODOP-UHFFFAOYSA-N (5-benzoyl-4,8-dihydroxynaphthalen-1-yl)-phenylmethanone Chemical compound C12=C(O)C=CC(C(=O)C=3C=CC=CC=3)=C2C(O)=CC=C1C(=O)C1=CC=CC=C1 UJBRSMKKNNODOP-UHFFFAOYSA-N 0.000 description 1
- OOSBCICQIJKSIO-UHFFFAOYSA-N (5-benzoylnaphthalen-1-yl)-phenylmethanone Chemical compound C=1C=CC2=C(C(=O)C=3C=CC=CC=3)C=CC=C2C=1C(=O)C1=CC=CC=C1 OOSBCICQIJKSIO-UHFFFAOYSA-N 0.000 description 1
- CYNRPHCWSKPLMN-UHFFFAOYSA-N (5-benzoylnaphthalen-2-yl)-phenylmethanone Chemical compound C=1C=C2C(C(=O)C=3C=CC=CC=3)=CC=CC2=CC=1C(=O)C1=CC=CC=C1 CYNRPHCWSKPLMN-UHFFFAOYSA-N 0.000 description 1
- RIGLBTSLVXOXPB-UHFFFAOYSA-N (6-benzoylnaphthalen-2-yl)-phenylmethanone Chemical compound C=1C=C2C=C(C(=O)C=3C=CC=CC=3)C=CC2=CC=1C(=O)C1=CC=CC=C1 RIGLBTSLVXOXPB-UHFFFAOYSA-N 0.000 description 1
- OTXHZHQQWQTQMW-UHFFFAOYSA-N (diaminomethylideneamino)azanium;hydrogen carbonate Chemical compound OC([O-])=O.N[NH2+]C(N)=N OTXHZHQQWQTQMW-UHFFFAOYSA-N 0.000 description 1
- JXPLNQNUEKAHEV-UHFFFAOYSA-N 1,5-diacetylanthracene-9,10-dione Chemical compound O=C1C2=C(C(C)=O)C=CC=C2C(=O)C2=C1C=CC=C2C(=O)C JXPLNQNUEKAHEV-UHFFFAOYSA-N 0.000 description 1
- GLGJFVRVRGKNPI-UHFFFAOYSA-N 1,8-diacetylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC(C(C)=O)=C2C(=O)C2=C1C=CC=C2C(=O)C GLGJFVRVRGKNPI-UHFFFAOYSA-N 0.000 description 1
- JBCVRTMLHPWTJI-UHFFFAOYSA-N 1-(10-acetylanthracen-9-yl)ethanone Chemical compound C1=CC=C2C(C(=O)C)=C(C=CC=C3)C3=C(C(C)=O)C2=C1 JBCVRTMLHPWTJI-UHFFFAOYSA-N 0.000 description 1
- GVAAPWYZIXMWLZ-UHFFFAOYSA-N 1-(8-acetylanthracen-1-yl)ethanone Chemical compound C1=CC(C(C)=O)=C2C=C3C(C(=O)C)=CC=CC3=CC2=C1 GVAAPWYZIXMWLZ-UHFFFAOYSA-N 0.000 description 1
- FQORHEMAUBKTGC-UHFFFAOYSA-N 1-(8-acetylnaphthalen-1-yl)ethanone Chemical compound C1=CC(C(C)=O)=C2C(C(=O)C)=CC=CC2=C1 FQORHEMAUBKTGC-UHFFFAOYSA-N 0.000 description 1
- UBNPGDBUJBXYRX-UHFFFAOYSA-N 10-benzoyl-10h-anthracen-9-one Chemical compound C12=CC=CC=C2C(=O)C2=CC=CC=C2C1C(=O)C1=CC=CC=C1 UBNPGDBUJBXYRX-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- FYLYHNXYIWQPDE-UHFFFAOYSA-N 2,6-dihydroxynaphthalene-1,5-dicarbaldehyde Chemical compound O=CC1=C(O)C=CC2=C(C=O)C(O)=CC=C21 FYLYHNXYIWQPDE-UHFFFAOYSA-N 0.000 description 1
- HIKCNBVIMHHBCH-UHFFFAOYSA-N 2,7-diacetylfluoren-1-one Chemical compound CC(=O)C1=CC=C2C3=CC=C(C(=O)C)C(=O)C3=CC2=C1 HIKCNBVIMHHBCH-UHFFFAOYSA-N 0.000 description 1
- CWXNCOWTIATRLD-UHFFFAOYSA-N 2-acetylfluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC(C(=O)C)=CC=C3C2=C1 CWXNCOWTIATRLD-UHFFFAOYSA-N 0.000 description 1
- NRGXLQRWUDCHBC-UHFFFAOYSA-N 2-aminoguanidine;hydrobromide Chemical compound Br.NNC(N)=N NRGXLQRWUDCHBC-UHFFFAOYSA-N 0.000 description 1
- PUYNGXBFZSNLCX-UHFFFAOYSA-N 7-oxobenzo[a]phenalene-2-carbaldehyde Chemical compound C1=C(C=C2C=CC=C3C(=O)C4=CC=CC=C4C1=C23)C=O PUYNGXBFZSNLCX-UHFFFAOYSA-N 0.000 description 1
- ORZGUASDMZFOOE-UHFFFAOYSA-N C(=O)C1=C(C=CC=C1)C1=CC=2C=CC=C(C=2C=C1)C=O Chemical compound C(=O)C1=C(C=CC=C1)C1=CC=2C=CC=C(C=2C=C1)C=O ORZGUASDMZFOOE-UHFFFAOYSA-N 0.000 description 1
- KGJIMZVBEATOLU-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)C=1C=CC2=CC=CC=3C4=CC=CC=C4C(C=1C=32)=O Chemical compound C(C1=CC=CC=C1)(=O)C=1C=CC2=CC=CC=3C4=CC=CC=C4C(C=1C=32)=O KGJIMZVBEATOLU-UHFFFAOYSA-N 0.000 description 1
- NOWRKJBUAZPYDA-UHFFFAOYSA-N C(CC)(=O)C=1C(C2=CC3=CC=CC=C3C2=CC1)=O Chemical compound C(CC)(=O)C=1C(C2=CC3=CC=CC=C3C2=CC1)=O NOWRKJBUAZPYDA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- UHVWCKZIHOXIRM-UHFFFAOYSA-N OC=1C=C(C=2C(C3=CC=CC=C3CC2C1)=O)C1=CC(=CC2=CC3=CC=CC=C3C=C12)O Chemical compound OC=1C=C(C=2C(C3=CC=CC=C3CC2C1)=O)C1=CC(=CC2=CC3=CC=CC=C3C=C12)O UHVWCKZIHOXIRM-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- YFPSDOXLHBDCOR-UHFFFAOYSA-N Pyrene-1,6-dione Chemical compound C1=CC(C(=O)C=C2)=C3C2=CC=C2C(=O)C=CC1=C32 YFPSDOXLHBDCOR-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XYTSTAWEGHCTHU-UHFFFAOYSA-N [2-(naphthalene-1-carbonyl)phenyl]-phenylmethanone Chemical compound C=1C=CC=C(C(=O)C=2C3=CC=CC=C3C=CC=2)C=1C(=O)C1=CC=CC=C1 XYTSTAWEGHCTHU-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 150000008365 aromatic ketones Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical class C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- VQNVZLDDLJBKNS-UHFFFAOYSA-N carbamimidoylazanium;bromide Chemical compound Br.NC(N)=N VQNVZLDDLJBKNS-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000005521 carbonamide group Chemical group 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical class N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- UKPBEPCQTDRZSE-UHFFFAOYSA-N cyclizine hydrochloride Chemical compound Cl.C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 UKPBEPCQTDRZSE-UHFFFAOYSA-N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- KMSRVXJGTIRNNK-UHFFFAOYSA-N diaminomethylideneazanium;hydrogen carbonate Chemical compound NC(N)=N.OC(O)=O KMSRVXJGTIRNNK-UHFFFAOYSA-N 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- PYHRFGZORIHOMQ-UHFFFAOYSA-N naphthalene-1,8-dicarbaldehyde Chemical compound C1=CC(C=O)=C2C(C=O)=CC=CC2=C1 PYHRFGZORIHOMQ-UHFFFAOYSA-N 0.000 description 1
- MNZMMCVIXORAQL-UHFFFAOYSA-N naphthalene-2,6-diol Chemical compound C1=C(O)C=CC2=CC(O)=CC=C21 MNZMMCVIXORAQL-UHFFFAOYSA-N 0.000 description 1
- WSPGRORDDACGQK-UHFFFAOYSA-N naphthalene-2,7-dicarbaldehyde Chemical compound C1=CC(C=O)=CC2=CC(C=O)=CC=C21 WSPGRORDDACGQK-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- LOOWWKXPYHZZDM-UHFFFAOYSA-N pentacene-5,12-dione Chemical compound O=C1C2=CC=CC=C2C=C2C1=CC1=CC3=CC=CC=C3C(=O)C1=C2 LOOWWKXPYHZZDM-UHFFFAOYSA-N 0.000 description 1
- FUTARTAINOHELR-UHFFFAOYSA-N perylene-3,10-dione Chemical compound C12=CC=CC(C(=O)C=C3)=C2C3=C2C3=C1C=CC=C3C(=O)C=C2 FUTARTAINOHELR-UHFFFAOYSA-N 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- 150000002988 phenazines Chemical class 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- AHXIPWMNLOHFTN-UHFFFAOYSA-N phenyl-(4,5,8-tribenzoylnaphthalen-1-yl)methanone Chemical compound C=1C=C(C(=O)C=2C=CC=CC=2)C2=C(C(=O)C=3C=CC=CC=3)C=CC(C(=O)C=3C=CC=CC=3)=C2C=1C(=O)C1=CC=CC=C1 AHXIPWMNLOHFTN-UHFFFAOYSA-N 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 150000003246 quinazolines Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 150000003252 quinoxalines Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
BUNDESREPUBLIK DEUTSCHLANDFEDERAL REPUBLIC OF GERMANY
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. CL:Int. CL:
C07cC07c
C07dC07d
Deutsche KL: 12 ο-17/04 German KL: 12 ο -17/04
Nummer: 1 239 291Number: 1 239 291
Aktenzeichen: F 42610IV b/12 οFile number: F 42610IV b / 12 ο
Anmeldetag: 15. April 1964Filing date: April 15, 1964
Auslegetag: 27. April 1967Open date: April 27, 1967
Es ist bekannt, daß Guanylhydrazone von polycyclischen Ketonen, die aromatische Ringe enthalten, eine bakteriostatische bzw. bakterizide Wirkung (deutsche Patentschrift 942 627, USA.-Patentschrift 2 865 961 sowie Zh. Oshch. Khim., 32 [1962], S. 1077) haben. Ebenso wurden Bis-guanylhydrazone von Diphenyl-diketonen und Diphenyl-dialdehyden (deutsche Patentschrift 943 408) sowie Monoguanylhydrazone von poylcycischen aromatischen Ketonen (Anales asoc. Argentina, 22 [1934], S. 41) beschrieben.It is known that guanylhydrazones of polycyclic Ketones that contain aromatic rings have a bacteriostatic or bactericidal effect (German patent specification 942 627, USA patent specification 2 865 961 and Zh. Oshch. Khim., 32 [1962], p. 1077) to have. Bis-guanylhydrazones of diphenyl-diketones and diphenyl-dialdehydes (German Patent 943 408) and monoguanyl hydrazones of polycycic aromatic ketones (Anales asoc. Argentina, 22 [1934], p. 41).
Die Erfindung betrifft ein Verfahren zur Herstellung von Guanylhydrazonen aromatischer polycyclischer Carbonylverbindungen bzw. deren Salzen mit nichttoxischen Säuren, das dadurch gekennzeichnet ist, daß man polycyclische aromatische Verbindungen, die mehr als eine Keto- bzw. Aldehydcarbonylgruppe enthalten, in jeweils an sich bekannter Weise entwederThe invention relates to a process for the preparation of guanylhydrazones of aromatic polycyclic Carbonyl compounds or their salts with non-toxic acids, which is characterized by that you have polycyclic aromatic compounds that have more than one keto or aldehyde carbonyl group included, either in a manner known per se
a) mit Aminoguanidinen der allgemeinen Formela) with aminoguanidines of the general formula
H2N — N — C — NHBH 2 N - N - C - NHB
E NA
oder deren Salzen umsetzt oderE NA
or converts their salts or
b) mit Thiosemicarbaziden der allgemeinen Formelb) with thiosemicarbazides of the general formula
H2N — N — C — NH- BH 2 N-N-C-NH-B
kondensiert und die Kondensationsprodukte entweder direkt oder nach ihrer Überführung in S-Alkylisothiosemicarbazone mit Aminen der allgemeinen Formelcondensed and the condensation products either directly or after their conversion into S-alkylisothiosemicarbazones with amines of the general formula
H2N-AH 2 NA
umsetzt oderimplements or
Verfahren zur Herstellung von Guanylhydrazonen aromatischer polycyclischer
CarbonylverbindungenProcess for the preparation of guanylhydrazones of aromatic polycyclic
Carbonyl compounds
Anmelder:Applicant:
Farbenfabriken Bayer Aktiengesellschaft,Paint factories Bayer Aktiengesellschaft,
LeverkusenLeverkusen
Als Erfinder benannt:Named as inventor:
Dr. Siegismund Schütz,Dr. Siegismund Schütz,
Dr. Karlheinz Meyer,Dr. Karlheinz Meyer,
Dr. Werner Meiser, Wuppertal-Elberfeld;Dr. Werner Meiser, Wuppertal-Elberfeld;
Dr. Kurt Stoepel, Wuppertal-Vohwinkel;Dr. Kurt Stoepel, Wuppertal-Vohwinkel;
Dr. Hans-Günther Kroneberg,Dr. Hans-Günther Kroneberg,
Wuppertal-ElberfeldWuppertal-Elberfeld
d) mit Hydrazinen der allgemeinen Forme]
H2N — NHd) with hydrazines of the general form]
H 2 N - NH
kondensiert und die erhaltenen Hydrazone mit Cyanamiden der allgemeinen Formelcondensed and the hydrazones obtained with cyanamides of the general formula
Ne= C —NH-BNe = C-NH-B
oder S-Alkylisothioharnstoffen der allgemeinen Formelor S-alkylisothioureas in general formula
NAN / A
Alkyl —S — C —NHBAlkyl-S-C-NHB
umsetztimplements
c) mit S-Alkylisothiosemicarbaziden der allgemeinen 40 und die erhaltenen Guanylhydrazone als solche oder Formel in Form ihrer Salze mit nichttoxischen Säuren isoliert.c) with S-alkylisothiosemicarbazides of the general 40 and the resulting guanylhydrazones as such or Formula isolated in the form of its salts with non-toxic acids.
In den vorstehend angegebenen Formeln stehen A und E für Wasserstoff oder einen verzweigten oder unverzweigten aliphatischen oder einen alicyclischenIn the formulas given above, A and E represent hydrogen or a branched or unbranched aliphatic or an alicyclic
E S — Alkyl 45 Rest mit jeweils 1 bis 6 Kohlenstoffatomen, die eineE S - alkyl 45 radical with 1 to 6 carbon atoms each, the one
oder mehrere Hydroxylgruppen tragen können; B bedeutet Wasserstoff, einen unsubstituierten oder mit einer oder mehreren Hydroxylgruppen substituierten alicyclischen oder verzweigten oder un-or can carry several hydroxyl groups; B means hydrogen, an unsubstituted or with one or more hydroxyl groups substituted alicyclic or branched or un-
H9N — N — C = NAH 9 N-N-C = NA
kondensiert und die erhaltenen Produkte mit Aminen der allgemeinen Formelcondensed and the products obtained with amines of the general formula
H2N-BH 2 NB
umsetzt oderimplements or
verzweigten aliphatischen Rest mit jeweils 1 bis Kohlenstoffatomen, wobei dieser Rest auch, gegebenenfalls über ein Stickstoff-, Sauerstoff- oderbranched aliphatic radical each having 1 to carbon atoms, this radical also, optionally via a nitrogen, oxygen or
709 577/361709 577/361
Schwefelatom, mit A verbunden sein kann, eine Nitro- oder eine Aminogruppe oder einen basischen Rest D. D steht für einen Rest der allgemeinen FormelSulfur atom, can be connected to A, a nitro or an amino group or a basic radical D. D stands for a radical of the general formula
(CH2)„—N:(CH 2 ) "- N:
R
R1 R.
R 1
in der η = 0 bis 8 und / 1 oder 2 sein kann und R und R1 jeweils für Wasserstoff, für gleiche oder verschiedene, unsubstituierte oder mit einer oder mehreren OH-Gruppen substituierte alicyclische oder verzweigte oder unverzweigte aliphatische Reste mit jeweils bis zu 6 Kohlenstoffatomen, die, gegebenenfalls auch über ein Stickstoff-, Schwefel- oder Sauerstoffatom, miteinander verbunden sein können, stehen.in which η = 0 to 8 and / 1 or 2 and R and R 1 each represent hydrogen, for identical or different, unsubstituted or alicyclic or branched or unbranched aliphatic radicals each with up to 6, which are unsubstituted or substituted by one or more OH groups Carbon atoms which, if appropriate, can also be connected to one another via a nitrogen, sulfur or oxygen atom.
Unter polycyclischen aromatischen Verbindungen sind hier Verbindungen mit zwei und mehr aromatischen Ringen zu verstehen, die auch N, S oder O als Heteroatome im Gerüst enthalten können. Hierbei müssen zwei aromatische Ringe durch zwei Bindungen, gegebenenfalls über N, S, C oder O als Brückenatome miteinander verknüpft sein.Polycyclic aromatic compounds here are compounds with two or more aromatic compounds To understand rings, which can also contain N, S or O as heteroatoms in the skeleton. Here must two aromatic rings through two bonds, optionally via N, S, C or O as bridge atoms be linked to each other.
Das aromatische System kann durch weitere aromatische Ringe substituiert sein. Diese polycyclischen Verbindungen können ferner in beliebiger Stellung durch OH, O—Alkyl, O-Acyl, NRR1, Halogen, Alkyl, Alkenyl, Alkinyl, Cycloalkyl, NO2, CN, Carboxyl, Carbonamid, SO2R oder Sulfonamid substituiert sein.The aromatic system can be substituted by further aromatic rings. These polycyclic compounds can also be substituted in any position by OH, O — alkyl, O-acyl, NRR 1 , halogen, alkyl, alkenyl, alkynyl, cycloalkyl, NO 2 , CN, carboxyl, carbonamide, SO 2 R or sulfonamide.
Geeignete Ausgangsmaterialien sind ζ. Β. Naphthalin-l,8-dialdehyd, Naphthalin-2,7-dialdehyd, 2-Acetylnaphthaldehyd, 1,5-Diacetylnaphthalin,Suitable starting materials are ζ. Β. Naphthalene-1,8-dialdehyde, naphthalene-2,7-dialdehyde, 2-acetylnaphthaldehyde, 1,5-diacetylnaphthalene,
1,8- Diacetylnaphthalin, 1,4- Dibenzoylnaphthalin, 1,5 - Dibenzoylnaphthalin, 1,6 - Dibenzoylnaphthalin, 2,6-Dibenzoylnaphthalin, 2,6-Dimethyl-l,5-dibenzoylnaphthalin, 1 - (o - Benzoylbenzoyl) - naphthalin, 6 - (o - Formylphenyl) -1 - naphthaldehyd, 4 - Hydroxy-1, 3 - dipropionylnaphthalin, 4,8 - Dihydroxy -1,5 - dibenzoylnaphthalin, 1,4,5,8-Tetrabenzoylnaphthalin, 2-Acetyliiuorenon, 2-Propionylfiuorenon, 1-Benzoylfluorenon, 4-BenzoyIfluorenon, 2,7-Diacetylfiuorenon, 2,7-Dibenzoylfluorenon, Biacendion, 5,5'-Diacetylbiacendion, 5,5'-Dibenzoylbiacendion, 9,10-Dibenzoylanthrazen,10-Benzoylanthron,3-(10-Anthronyl)-indan-1-on, 10- Hydroxy-1,5 - bis - (2,4- dimethylbenzoyl) - anthron, 1,3-Dibenzoylanthrazen, 2,6-Dibenzoylanthrazen, Bianthron, 3,3'-Dihydroxybianthron, 9,10-Bis-(« - phenylacetonyliden) - 9,10 - dihydroreten, 9,10 - Dihydroxy - 9,10 - diacetonyl - 9,10 - dihydrophenanthren, 1,5 - Diacetylanthrachinon, 1,8 - Diacetylanthrachinon, 2,8-Chrysochinon, 1,6-Dibenzoylpyren, 3,8-Dibenzoylpyren, Pyren-3,8-chinon, Pyren-3,10-chinon, Benzanthron-2-aldehyd, 6-Benzoylbenzanthron, Pentacen-5,12-chinon, 3,4-Benzopyren-5,10-chinon, Perylen-3,10-chinon, !,ll-Dimethyl-perylen-S.lO-chinon.1,8- diacetylnaphthalene, 1,4- dibenzoylnaphthalene, 1,5 - dibenzoylnaphthalene, 1,6 - dibenzoylnaphthalene, 2,6-dibenzoylnaphthalene, 2,6-dimethyl-1,5-dibenzoylnaphthalene, 1 - (o - Benzoylbenzoyl) - naphthalene, 6 - (o - Formylphenyl) -1 - naphthaldehyde, 4 - hydroxy-1, 3 - dipropionylnaphthalene, 4,8 - dihydroxy -1,5 - dibenzoylnaphthalene, 1,4,5,8-tetrabenzoylnaphthalene, 2-acetylfluorenone, 2-propionylfluorenone, 1-benzoylfluorenone, 4-BenzoyIfluorenone, 2,7-Diacetylfluorenone, 2,7-dibenzoylfluorenone, biacendione, 5,5'-diacetylbiacendione, 5,5'-dibenzoylbiacendione, 9,10-dibenzoylanthracene, 10-benzoylanthrone, 3- (10-anthronyl) indan-1-one, 10-hydroxy-1,5 - bis - (2,4-dimethylbenzoyl) - anthrone, 1,3-dibenzoylanthracene, 2,6-dibenzoylanthracene, Bianthrone, 3,3'-dihydroxybianthrone, 9,10-bis (« - phenylacetonylidene) - 9.10 - dihydroretene, 9.10 - dihydroxy - 9.10 - diacetonyl - 9.10 - dihydrophenanthrene, 1,5 - diacetylanthraquinone, 1,8 - diacetylanthraquinone, 2,8-chrysoquinone, 1,6-dibenzoylpyrene, 3,8-dibenzoylpyrene, Pyrene-3,8-quinone, pyrene-3,10-quinone, benzanthrone-2-aldehyde, 6-benzoylbenzanthrone, pentacene-5,12-quinone, 3,4-benzopyrene-5,10-quinone, perylene-3,10-quinone, I, II-dimethyl-perylene-S.lO-quinone.
Gleichfalls geeignet sind analoge Derivate des Chinolins, Isochinolins, Carbazole, Acridins, Phenanthridins, 1,2-Benzodiazins, Chinazolins, Chinoxalins, Phenazins, Phenazons, Phenanthrolins, Thioxanthens, Thiosanthons, Phenoxazins, Phenothiazine, Diphenylsulfon, Diphenylenoxyd, Xanthon.Analogous derivatives of quinoline, isoquinoline, carbazole, acridine, phenanthridine, 1,2-benzodiazines, quinazolines, quinoxalines, phenazines, phenazons, phenanthrolines, thioxanthens, Thiosanthone, phenoxazine, phenothiazine, diphenyl sulfone, diphenylene oxide, xanthone.
Die erfindungsgemäß herstellbaren Verbindungen müssen mindestens zwei Guanylhydrazongruppen enthalten, die auch über aliphatische oder alicyclische Reste mit 1 bis 10 Kohlenstoffatomen an den PoIycyclus gebunden sein können. Diese Guanylhydrazone wirken ähnlich wie Herzglycoside, d. h., sie steigern die Kontraktionskraft der Herzmuskulatur. Sie sind anwendbar als solche oder in Form ihrer Salze mit nichttoxischen organischen oder anorganischen Säuren. Geeignete Säuren sind z. B. Essigsäure, Propionsäure, Milchsäure, Maleinsäure, Fumarsäure, Bernsteinsäure, Weinsäure, Zitronensäure, Salicylsäure, Naphthalin-l,5-disulfonsäure, Phosphorsäure und Salzsäure. Die Erzeugnisse des erfindungsgemäßen Verfahrens haben eine positiv inotrope Herzmuskelwirkung, ίο welche in den folgenden Versuchsanordnungen nachgewiesen werden konnte:The compounds which can be prepared according to the invention must have at least two guanylhydrazone groups Contain, which also via aliphatic or alicyclic radicals with 1 to 10 carbon atoms on the Polycyclus can be bound. These guanylhydrazones act similarly to cardiac glycosides, i. i.e., they increase the force of contraction of the heart muscles. They are applicable as such or in the form of their salts with non-toxic organic or inorganic acids. Suitable acids are e.g. B. acetic acid, propionic acid, Lactic acid, maleic acid, fumaric acid, succinic acid, tartaric acid, citric acid, salicylic acid, naphthalene-l, 5-disulfonic acid, Phosphoric acid and hydrochloric acid. The products of the method according to the invention have a positive inotropic cardiac muscle effect, ίο which has been demonstrated in the following test arrangements could be:
1. Isoliertes spontan schlagendes Herzvorhofspräparat des Meerschweinchens. Methode s.1. Isolated spontaneously beating atrial preparation of the guinea pig. Method s.
P. H ο 11 ζ und E. Westermann, Naunyn-Schmiedebergs Arch. exp. Path. u. Pharmak., 225, S. 421 (1955), sowie G. Kroneberg und K. S t ο e ρ e 1, Naunyn-Schmiedebergs Arch. exp. Path. u. Pharmak., 249, S. 394 (1964).P. H ο 11 ζ and E. Westermann, Naunyn-Schmiedebergs Arch. Exp. Path. and Pharmak., 225, p. 421 (1955), as well as G. Kroneberg and K. S tο e ρ e 1, Naunyn-Schmiedebergs Arch. Exp. Path. and Pharmak., 249, p. 394 (1964).
2. Messung der intracardialen Druckanstiegssteilheit. Methode s. J. H a m a c h e r, Naunyn-Schmiedebergs Arch. exp. Path. u. Pharmak., 244, S. 429 (1963).2. Measurement of the steepness of the intracardial pressure increase. Method see J. Ha macher, Naunyn-Schmiedebergs Arch. Exp. Path. and Pharmak., 244, p. 429 (1963).
3. Hemmung der Transport-ATPase des Meerschweinchenherzens
(K. R e ρ k e und H. J. P ο r t i u s, Experientia, 19, S. 452 [1963]).
Gewinnung der Transport-ATPase nach T. K ο no und S. P. Collowick , Arch. Biochem.
Biophys., 93, S. 520 bis 533 (1961).
Bestimmung der Enzymaktivität nach J. V. A u d i t ο r e, Proc. Soc. exp. Biol. Med., 110,
S. 595 bis 597 (1962).
35 3. Inhibition of the transport ATPase of the guinea pig heart (K. R e ρ ke and HJ P ο rtius, Experientia, 19, p. 452 [1963]).
Obtaining the transport ATPase according to T. Ko no and SP Collowick, Arch. Biochem. Biophys., 93, pp. 520-533 (1961).
Determination of the enzyme activity according to JV A udit ο re, Proc. Soc. exp. Biol. Med., 110, pp. 595-597 (1962).
35
UntersuchungsergebnisseInvestigation results
Bisguanylhydrazon-dihydrochloridBisguanyl hydrazone dihydrochloride
des 1,8-Diacetyl-anthrazensof 1,8-diacetyl anthracene
Toxizität, MausToxicity, mouse
6,3 bis 8,0 mg/kg i. v.6.3 to 8.0 mg / kg i.p. v.
Herzvorhof, MeerschweinchenAtrium, guinea pigs
Positiv inotrope Wirkung ab Konzentrationen von 3 · 10~8 g/ml. Herzmuskelkontraktur und Stillstand bei Konzentrationen von 3 · 10~s g/ml.Positive inotropic effect from concentrations of 3 · 10 ~ 8 g / ml. Cardiac muscle contracture and arrest at concentrations of 3 x 10 ~ s g / ml.
Intracardiale Druckanstiegssteilheit an der KatzeIntracardiac pressure rise steepness in the cat
Vergrößerung der Druckanstiegssteilheit um 65 °/e nach i. v.-Infusion von 2,8 mg/kg.Increase in the rate of pressure rise by 65 ° / e after iv infusion of 2.8 mg / kg.
Transport-ATPase, MeerschweinchenTransport ATPase, guinea pig
Bei Konzentrationen von 10~s molar = 49% Hemmung.At concentrations of 10 ~ s molar = 49% inhibition.
Bisguanylhydrazon-dihydrobromid
des 3,6-Diacetyl-diphenylenoxydsBisguanylhydrazone dihydrobromide
of 3,6-diacetyl-diphenylene oxide
Toxizität, MausToxicity, mouse
20 bis 25 mg/kg i. v.20 to 25 mg / kg i.p. v.
g Herzvorhof, Meerschweincheng atrium, guinea pigs
Positiv inotrope Wirkung ab Konzentrationen von 3 · 10~6 g/ml. Herzmuskelkontraktur und Stillstand bei Konzentrationen von 10~5 g/ml.Positive inotropic effect from concentrations of 3 · 10 ~ 6 g / ml. Heart muscle contracture and arrest at concentrations of 10 ~ 5 g / ml.
5 65 6
Bisguanylhydrazon-dihydrochlorid Analog erhält man durch Umsetzung von 1-(/S-Di-Bisguanylhydrazone dihydrochloride is obtained analogously by reacting 1 - (/ S-di-
des !,S-Diacetyl^o-dihydroxynaphthalins äthylammoäthyl)-3-aminoguanidin bzw. 1-Nitro-des!, S-diacetyl ^ o-dihydroxynaphthalene (ethylammoethyl) -3-aminoguanidine or 1-nitro-
3-aminoguanidin mit dem Diacetylanthrazengemisch3-aminoguanidine with the diacetyl anthracene mixture
Toxizität, Maus die Tetrahydrochloride der Bis-l-(ß-diäthylamino-Toxicity, mouse the tetrahydrochloride of the bis-l- (ß-diethylamino-
8,0 bis 9 0 mg/kg i ν 5 ä1%I)-guanylhydrazone bzw. die Bis-(l-nitroguanyl-8.0 to 90 mg / kg i ν 5 - 1% I) -guanylhydrazones or the bis- (l-nitroguanyl-
hydrazone) der Diacetylanthrazene, die bei 280 bzw. Herzvorhof, Meerschweinchen 250°C schmelzen.hydrazone) of the diacetylanthracenes, which melt at 280 or atrium, guinea pigs 250 ° C.
Positiv inotrope Wirkung ab Konzentrationen
von 3 · 10-5 g/ml. 10 B e i s ρ i e 1 2Positive inotropic effect from concentrations
3 × 10 -5 g / ml. 10 B eis ρ ie 1 2
Intracardiale Druckanstiegssteilheit nach Hamacher 7,7 g 3,6-Diacetyl-diphenylenoxyd werden in 250 mlIntracardial pressure increase gradient according to Hamacher 7.7 g of 3,6-diacetyl-diphenylene oxide are in 250 ml
am Meerschweinchen heißem absolutem Alkohol gelöst und mit einerdissolved in hot absolute alcohol on the guinea pig and mixed with a
Lösung von 9,5 g Aminoguanidinhydrobromid inSolution of 9.5 g of aminoguanidine hydrobromide in
Vergrößerung der Druckanstiegssteilheit um 105% 15 9 m\ Wasser sowie einigen Tropfen Bromwasserstoffnach 0,05 mg/kg i. m. säure versetzt. Man engt etwas ein, saugt den ausIncrease in pressure rise by 105% 15 9 m \ water and a few drops of hydrogen bromide after 0.05 mg / kg in acid. You narrow it in, suck it out
kristallisierenden Niederschlag ab und kristallisiertcrystallizing precipitate and crystallized
„. „ , ,., , ,, ·. aus Methanol um.". “,,.,, ,, ·. from methanol.
Bisguanylhydrazon-dihydrochlorid Man ^1 U1 Dihydrobromid des 3,6-Diace-Bisguanylhydrazone Dihydrochlorid Man ^ 1 U1 Dihydrobromid des 3,6-Diace-
des3,6-Diacetyl-diphenylensulfids 2o tyldiphenylenoxyd-bisguanylhydrazons; Zersetzungs-des3,6-diacetyl-diphenylene sulfide 2o tyldiphenylenoxyd-bisguanylhydrazone; Decomposition
Toxizität, Maus Punkt 355° C.Toxicity, mouse point 355 ° C.
12,5 bis 16,0 mg/kg i. v. B e i s ρ i e 1 312.5 to 16.0 mg / kg i.p. v. B e i s ρ i e 1 3
rT ,j-»,,·, l>2g Aminoguanidinhydrogencarbonat werden in rT , j - »,, ·, l> 2g aminoguanidine hydrogen carbonate are used in
Herzvorhof, Meerschweinchen 25 methanolischer Salzsäure bis zum pH-Wert = 2 gelöstAtrium, guinea pigs dissolved 25 methanolic hydrochloric acid to pH = 2
Positiv inotrope Wirkung ab Konzentrationen und mit einer Lösung von 1 g l,5-Diacetyl-2,6-di-Positive inotropic effect from concentrations and with a solution of 1 g of l, 5-diacetyl-2,6-di-
von 3 · 10~6 g/ml. Herzmuskelkontraktur und hydroxynaphthalin in Äthanol versetzt. Man läßt Stillstand bei Konzentrationen von 3 · 10~5 g/ml. 3 Tage unter Stickstoff bei Raumtemperatur stehen,from 3 x 10 ~ 6 g / ml. Heart muscle contracture and hydroxynaphthalene added to ethanol. The mixture is left standstill at concentrations of 3 x 10 -5 g / ml. Stand under nitrogen at room temperature for 3 days,
rührt in Äther ein, dekantiert, löst den zähen Rück-stirs in ether, decants, dissolves the tough back
30 stand in Äthanol und rührt abermals in Äther ein.30 stood in ethanol and stirs again into ether.
Bisguanylhydrazon-dihydrochlorid Die ausfallenden Flocken werden abgesaugt und meh-Bisguanylhydrazone dihydrochloride The flakes that precipitate are suctioned off and several
des 1,5-Diacetyl-naphthalins rere Male mit Aceton ausgekocht.of 1,5-diacetyl-naphthalene rer e times boiled with acetone.
Toxizität, Maus Man erhält 1,7 g Dihydrochlorid des 1,5-Diacetyl-Toxicity, mouse 1.7 g of dihydrochloride of 1,5-diacetyl-
,.'.„„ „ . 2,6-dihydroxynaphthalin-bisguanylhydrazons. F.280°C,. '. "" ". 2,6-dihydroxynaphthalene-bisguanylhydrazone. 280 ° C
8,0 bis 9,0 mg/kg i.v. 35 (Zersetzung).8.0 to 9.0 mg / kg i.v. 35 (decomposition).
Herzvorhof, Meerschweinchen Beispiel 4Atrium, guinea pig Example 4
Positiv inotrope Wirkung ab Konzentrationen 2,68 g 3,6-Diacetyldiphenylensulfid werden in derPositive inotropic effects from concentrations of 2.68 g of 3,6-diacetyldiphenylene sulfide are found in the
von 3 · 10^7 g/ml. Herzmuskelkontraktur ab Kon- Hitze in 30 ml Dimethylformamid gelöst und mit der zentrationen von 3 · 10"6 g/ml. 40 Lösung von 2,2 g Aminoguanidinhydrochlorid inof 3 x 10 ^ 7 g / ml. Heart muscle contracture from concentration dissolved in 30 ml of dimethylformamide and with a concentration of 3 · 10 " 6 g / ml. 40 solution of 2.2 g of aminoguanidine hydrochloride in
2,5 ml Wasser versetzt. Man gibt 6 Tropfen konzen-2.5 ml of water are added. Add 6 drops of concentrated
Intracardiale Druckanstiegssteilheit nach Hamacher trierte Salzsäure zu und erhitzt 1 Stunde auf dem am Meerschweinchen Wasserbad. Man filtriert, fällt mit Essigester undIntracardial pressure rise steepness according to Hamacher trated hydrochloric acid and heated for 1 hour on the on the guinea pig water bath. It is filtered, precipitated with ethyl acetate and
Vergrößerung der Druckanstiegssteilheit um 60% Wä^ht mit, 5f^Ster°f*V ,, .. . - , n. Increasing the pressure increase gradient to 60% Wä ^ ht, 5f ,, ^ Ster ° f * V ... -, n .
nach 0 05 mff/Icff i m 45 Man erhalt 3,7 g Dihydrochlond des 3,6-Diace-after 0 05 mff / Icff im 45 You get 3.7 g of dihydrochloride of 3,6-Diace-
nacn υ,υο mg/Kg 1. m. tyldiphenylensulfid-bisguanylhydrazons. F 331°C(Zer-nacn υ, υο mg / kg 1. m. tyldiphenylene sulfide bisguanylhydrazone. F 331 ° C (decomposition
setzung).setting).
Alle bis zum Anmeldetag bekannten Stoffe mit Beispiel 5
einer herzglycosidartigen Wirkung werden aus Pfianzen-All substances known up to the filing date with example 5
a cardiac glycoside-like effect are produced from plant
extrakten gewonnen, sind also Naturstoffe. Dagegen 50 Wie im Beispiel 3 erhält man aus 1,5-Diacetyl-Extracts obtained are therefore natural substances. In contrast, 50 As in Example 3, 1,5-diacetyl-
handelt es sich bei den erfindungsgemäß herstellbaren 2,6-dihydroxynaphthalin und l,2-Äthylen-3-amino-it is the 2,6-dihydroxynaphthalene and 1,2-ethylene-3-amino-
neuen Substanzen um die ersten synthetischen Stoffe guanidin-hydrobromid das Dihydrobromid des 1,5-Di-new substances around the first synthetic substances guanidine hydrobromide the dihydrobromide of the 1,5-di-
mit herzglycosidartiger Wirkung. acetyl^ö-dihydroxynaphthalin-bis-il^-äthylen-guanyl-with a cardiac glycoside-like effect. acetyl ^ ö-dihydroxynaphthalene-bis-il ^ -ethylene-guanyl-
Die folgenden Beispiele erläutern die Erfindung. hydrazons). F. 210 bis 213° C (Zersetzung).The following examples illustrate the invention. hydrazone). M.p. 210 to 213 ° C (decomposition).
Beispiel 1 . . ,Example 1 . . ,
2,6 g eines Gemisches aus 1,5- und 1,8-Diacetyl-2.6 g of a mixture of 1,5- and 1,8-diacetyl-
anthrazen vom Schmelzpunkt 185 0C werden in 70 ml Analog zu Beispiel 3 erhält man, ausgehend vonanthracene of melting point 185 0 C in 70 ml analogously to Example 3, starting from
Chloroform gelöst, mit einer Lösung von 2,9 g Amino- 60 l,5-Diacetyl-2,6-dihydroxynaphthalin und 1-Äthyl-Dissolved chloroform, with a solution of 2.9 g of amino 60 l, 5-diacetyl-2,6-dihydroxynaphthalene and 1-ethyl
guanidinhydrogencarbonat in methanolischer Salz- 3-aminoguanidin-hydrochlorid, das Dihydrochloridguanidine hydrogen carbonate in methanolic salt 3-aminoguanidine hydrochloride, the dihydrochloride
säure versetzt (pH = 2) und 2 Tage bei Raumtempe- des !,S-Diacetyl^ö-dihydroxynaphthalin-bis-Cl-äthyl-acid added (pH = 2) and 2 days at room temperature!, S-diacetyl ^ ö-dihydroxynaphthalene-bis-Cl-ethyl-
ratur gerührt. Man saugt den ausgefallenen Nieder- guanylhydrazons). F. 1800C (Zersetzung),
schlag ab und kristallisiert aus Äthanol unter Zusatzrature stirred. The precipitated lower guanylhydrazone is sucked. F. 180 0 C (decomposition),
knock off and crystallize from ethanol with addition
von etwas Wasser um. Ausbeute 1,1 g. 65 .of some water around. Yield 1.1g. 65.
Das erhaltene Gemisch aus den Dihydrochloriden Beispiel /The mixture obtained from the dihydrochlorides Example /
der Bisguanylhydrazone der Diacetylanthrazene Wie im Beispiel 3 erhält man aus l,5-Diacetyl-2,6-di-the bisguanylhydrazones of the diacetylanthracenes As in Example 3, 1,5-diacetyl-2,6-di-
schmilzt bei 335 bis 337°C. hydroxynaphthalin und l-Nitro-3-aminoguanidin dasmelts at 335 to 337 ° C. hydroxynaphthalene and l-nitro-3-aminoguanidine das
1010
Bis-(l-nitroguanylhydrazon) des l,5-Diacetyl-2,6-dihydroxynaphthalins. F. 1600C (Zersetzung).Bis- (l-nitroguanylhydrazone) des 1,5-diacetyl-2,6-dihydroxynaphthalene. F. 160 0 C (decomposition).
Analog zu Beispiel 1 erhält man aus 1,5-Diacetylnaphthalin und Ammoguanidin das Dihydrochlorid des 1,5 - Diacetylnaphthalin - bisguanylhydrazons. F. > 300aC.Analogously to Example 1, the dihydrochloride of 1,5-diacetylnaphthalene-bisguanylhydrazone is obtained from 1,5-diacetylnaphthalene and ammoguanidine. F.> 300 a C.
Analog zu Beispiel 3 erhält man aus 1,5-Diformyl-2,6-dihydroxynaphthalin und Aminoguanidin-hydrochlorid das Dihydrochlorid des l,5-Diformyl-2,6-dihydronaphthalin-bisguanylhydrazons. F. 295 0C (Zer-Setzung). Analogously to Example 3, the dihydrochloride of 1,5-diformyl-2,6-dihydronaphthalene-bisguanylhydrazone is obtained from 1,5-diformyl-2,6-dihydroxynaphthalene and aminoguanidine hydrochloride. F. 295 0 C (decomposition).
B e i s ρ i e 1 10B e i s ρ i e 1 10
Analog zu Beispiel 3 erhält man aus 1,5-Diacetyl-2,6-dihydroxynaphthalin und !'-(/S-Pyrrolidin-äthyl)-3-aminoguanidin-trihydrochlorid das Tetrahydrochlorid des 1,5-Diacetyl-2,6-dihydroxynaphthalin-bis-[l'-(j5-pyrrolidin-äthyl)-guanylhydrazons]. F. 192°C (Zersetzung).In a manner analogous to Example 3, 1,5-diacetyl-2,6-dihydroxynaphthalene is obtained and! '- (/ S-pyrrolidine-ethyl) -3-aminoguanidine-trihydrochloride the tetrahydrochloride of 1,5-diacetyl-2,6-dihydroxynaphthalene-bis- [l '- (j5-pyrrolidine-ethyl) -guanylhydrazone]. 192 ° C (decomposition).
Claims (1)
oder deren Salzen umsetzt oderE NA
or converts their salts or
umsetzt oderH 2 NB
implements or
umsetztAlkyl - S - C - NHB
implements
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1053035D GB1053035A (en) | 1964-04-15 | ||
| DE1964F0042610 DE1239291B (en) | 1964-04-15 | 1964-04-15 | Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1964F0042610 DE1239291B (en) | 1964-04-15 | 1964-04-15 | Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1239291B true DE1239291B (en) | 1967-04-27 |
Family
ID=7099171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1964F0042610 Pending DE1239291B (en) | 1964-04-15 | 1964-04-15 | Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compounds |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE1239291B (en) |
| GB (1) | GB1053035A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3686222A1 (en) * | 2012-10-19 | 2020-07-29 | Zeon Corporation | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4258181A (en) * | 1978-09-05 | 1981-03-24 | American Cyanamid Company | Substituted 9,10-anthracenebishydrazones |
| FR2446285A1 (en) * | 1978-09-05 | 1980-08-08 | American Cyanamid Co | Bis:hydrazone derivs. of anthracene 9,10-di:carbonyl cpds. - useful as antibacterials and antitumour agents |
-
0
- GB GB1053035D patent/GB1053035A/en active Active
-
1964
- 1964-04-15 DE DE1964F0042610 patent/DE1239291B/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3686222A1 (en) * | 2012-10-19 | 2020-07-29 | Zeon Corporation | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1053035A (en) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0281902B1 (en) | Bis-naphthalimides, their preparation and use | |
| DE2402398B2 (en) | Aromatic carboxamide derivatives, processes for their preparation and pharmaceutical compositions | |
| DE2921660A1 (en) | 5-NITROIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTIPROTOZONE AGENTS CONTAINING THESE COMPOUNDS | |
| DE1163838B (en) | Process for the preparation of dibenzo [c, e] [1,2] - thiazine-5, 5-dioxide derivatives | |
| DE1239291B (en) | Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compounds | |
| DE1175247B (en) | Process for the preparation of N, N-disubstituted mono- (aminoalkyl) amides | |
| DE1239292B (en) | Process for the preparation of guanylhydrazones of araliphatic carbonyl compounds | |
| DE1230031B (en) | Process for the preparation of derivatives of naphthalene-1, 4, 5, 8-tetracarboxylic acid diimide | |
| EP0243841A1 (en) | Benzo[d,e]isoquinoline-1,3 diones, their preparation and use | |
| DE1238896B (en) | Process for the preparation of guanylhydrazones of aliphatic carbonyl compounds | |
| DE964495C (en) | Process for the preparation of a new thiosemicarbazide | |
| DE1287582B (en) | Process for the preparation of disubstituted isoxazole compounds and their non-toxic salts | |
| DE2649855C2 (en) | Substituted 5-acetyl-4-hydroxy-3-phenylamino-2H-pyran-2,6(3H)-diones, processes for their preparation and their use | |
| DE1225169B (en) | Process for the preparation of basic substituted oximes of 5H-dibenzo [a, d] -10,11-dihydro-cyclohepten-5-one | |
| DE1241816B (en) | Process for the production of new sulfonylureas | |
| AT126139B (en) | Process for the preparation of basic nitro derivatives of 9-aminoacridine. | |
| DE1235929B (en) | Process for the preparation of 2- (2'-pyrazinyl) benzimidazole and its salts | |
| DE2917997A1 (en) | SUBSTITUTED PYRROLIDINYL-BENZOESAEUR DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| DE2102848C3 (en) | Process for the preparation of N- (diethylaminoethyl) benzamides | |
| DE856297C (en) | Process for the production of 3- (2-oxy-phenyl) -pyrazole or its substitution products | |
| DE1795610C3 (en) | Process for the production of crystalline, non-hygroscopic cephaloridin | |
| AT227683B (en) | Process for the production of new anthranilic acids and their salts | |
| DE3243820C2 (en) | N-Isopropylnoratropine N-oxide, process for its manufacture and pharmaceutical preparations containing it | |
| DE1793541C2 (en) | Carboxy lmethyl 1-dithiocarbamic acids, processes for their production and pharmaceutical preparations containing such active ingredients. Elimination from: 1568302 | |
| DE285604C (en) |